Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The eukaryotic translation elongation factor 1 alpha 1 pseudogene (ENSG00000270413) is a processed pseudogene derived from the parental gene EEF1A1, which encodes a key component of the protein translation machinery in eukaryotes. Unlike its parent gene, the pseudogene does not code for a functional protein and generally has no direct biological activity. Pseudogenes, however, may play indirect regulatory roles in gene networks, particularly via non-coding RNAs, and their aberrant expression has been implicated in cancer and other diseases. The presence of pseudogenes can complicate genetic analysis and diagnostic workflows, but they are not considered therapeutic targets[2][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation elongation factor 1 alpha 1 pseudogene.